EU Ministers To Debate Pharma ‘Market Failures And High Prices’
Closer Member State Cooperation Is On The Agenda
Varying levels of access to medicines across the EU are the result of market failures, high prices and pharmaceutical companies’ marketing strategies, says the Council of the EU, which will discuss these issues at the next meeting of European health ministers.
